[The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies].
作者信息
Salvati F, Mugnaini L, Altieri A M, De Marinis F
出版信息
Clin Ter. 1979 Jan 15;88(1):45-50.
PMID:436377
Abstract
摘要
相似文献
1
2
[Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].[利福平在肺结核患者长期治疗中的耐受性]
Probl Tuberk. 1976 Feb(21):34-9.
3
[Use of rifampicin in tuberculous patients with liver diseases].[利福平在肝病结核患者中的应用]
G Ital Chemioter. 1972 Jul;19(3):63-8.
4
Side effects of rifampicin. A clinical study.利福平的副作用。一项临床研究。
Scand J Respir Dis Suppl. 1973;82:1-52.
5
[The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].[利福平的肝毒性及其通过“必需”胆碱磷脂的修饰]
Med Welt. 1978 Mar 17;29(11):452-4.
6
A trial of intermittent rifampicin and ethambutol in retreatment regimens.
Scand J Respir Dis Suppl. 1973;84:132-5.
7
Rifampicin hepatitis. A clinical and histological study.利福平肝炎。一项临床与组织学研究。
Lancet. 1974 Mar 16;1(7855):421-5. doi: 10.1016/s0140-6736(74)92381-2.
8
[Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].[利福平。200例患者抗结核作用及其肝脏耐受性的研究]
Lille Med. 1972 May;17(5):755-61.
9
Hepatorenal failure with self-initiated intermittent rifampicin therapy.自行开始间歇性利福平治疗导致肝肾衰竭。
Br Med J. 1974 Jun 1;2(5917):481-2. doi: 10.1136/bmj.2.5917.481.
10
[Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].[利福平治疗活动性肺结核。异烟肼-利福平-硫卡利得与异烟肼-链霉素-硫卡利得治疗初治肺结核的对照试验。利福平-乙胺丁醇-硫卡利得联合治疗复发肺结核]
Schweiz Med Wochenschr. 1974 Mar 9;104(10):356-64.
Zotero 插件